ArticleEMBO reports2026
Developing a mobile RNA delivery system for grafting trait improvement.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Systemic RNA movement offers a route for non-transgenic trait improvement by grafting, but progress has been limited by the lack of reliable tools to identify mobile RNA elements. Here, we report a fluorescence-aptamer-based live-imaging platform for screening mobile RNAs and mapping mobility elements. In a transient screening assay, live imaging of 100 RNA-seq-predicted candidates detects three reproducibly mobile mRNAs, CAT3, CK1, and GAI, under our assay conditions, with GAI mRNA exhibiting the highest bidirectional mobility. Truncation analysis defines two independent 30-nt cis-elements, GME1 in the coding region and GME2 in the 3'UTR, with GME2 mediating a higher transport rate and mobility rate. A tandem 2×GME2 cassette in the 3'UTR functions as a high-capacity RNA delivery module and, in our transient assay, outperforms the tRNA-like sequence motif (TLS; tRNA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.